Prognostic Clinicopathologic Factors in Cutaneous T-cell Lymphoma

Archives of Dermatology

Volumn 127, Issue 10, 1991, Pages 1511-1516

  Martí, Rosa M ^a   Estrach, Teresa ^a   Reverter, Juan C ^a   Mascaró, José M ^a  

^a HOSPITAL CLÍNIC   (Spain)

Author keywords

[No Author keywords available]

Indexed keywords

ADULT; ARTICLE; CLINICAL ARTICLE; FEMALE; HUMAN; MALE; PRIORITY JOURNAL; PROGNOSIS; SKIN CANCER; T CELL LYMPHOMA;

ADULT; AGED; AGED, 80 AND OVER; FEMALE; HUMAN; LYMPHOMA, T-CELL, CUTANEOUS; MALE; MIDDLE AGE; NEOPLASM STAGING; PROGNOSIS; SKIN NEOPLASMS; SURVIVAL ANALYSIS;

EID: 0026052528     PISSN: 0003987X     EISSN: 15383652     Source Type: Journal    
DOI: 10.1001/archderm.1991.01680090075007     Document Type: Article

References (38)

1. Lutzner M, Edelson R, Schein PH, Green I, Kirkpatrick C, Ahmed A. Cutaneous T-cell lymphomas: the Sézary syndrome, mycosis fungoides and related disorders. Ann Intern Med. 1975; 83: 534-552.
2. Berger CL, Warburton D, Raafat J, LoGerfo D, Edelson RL. Cutaneous T-cell lymphoma: neoplasm of T cells with helper activity. Blood. 1979; 53: 642-651.
3. Broder S, Edelson RL, Lutzner MA, et al. The Sézary syndrome: a malignant proliferation of helper T cells. J Clin Invest. 1976; 58: 1297-1306.
4. Chu AC. The use of monoclonal antibodies in the in situ identification of T-cell subpopulations in cutaneous T-cell lymphoma. J Cutan Pathol. 1983; 10: 479-498.
5. McMillan EM. Monoclonal antibodies and cutaneous T-cell lymphoma: theoretical and practical considerations. J Am Acad Dermatol. 1985; 12: 102-114.
6. Ralfkiaer E, Wantzin GL, Mason DY, Hou-Jansen K, Stein H, Thomson K. Phenotypic characterization of lymphocytic subsets in mycosis fungoides: comparison with large plaque parapsoriasis and benign chronic dermatoses. Am J Clin Pathol. 1985; 84: 610-619.
7. Aisenberg AC, Krontiris TG, Mak TW, Wilkes BM. Rearrangement of the gene for the beta chain of the T-cell receptor in T-cell chronic lymphocytic leukemia and related disorders. N Engl J Med. 1985; 313: 529-533.
8. Bertness V, Kirsch I, Hollis G, Johnson B, Bunn PA. T-Cell receptor gene rearrangements as clinical markers of human T-cell lymphomas. N Engl J Med. 1985; 313: 534-538.
9. Weiss LM, Hu E, Wood C, Cleary M, Warnke R, Sklar J. Clonal rearrangements of T-cell receptor genes in mycosis fungoides and dermatopathic lymphadenopathy. N Engl J Med. 1985; 313: 539-544.
10. Alibert JL. Description des maladies de la peau observées a l'Hôpital de St Louis et exposition des meilleurs méthodes suivies pour leur traitement. Paris, France: Barrois L'ainé et Fils; 1806: 157.
11. Sézary A, Bouvrain Y. Erythoderma avec présence de cellules monstrueuses dans la derme el le sang circulant. Bull Soc Fr Dermatol Syphil. 1938; 45: 254-260.
12. Edelson RL. Cutaneous T-cell lymphoma. J Dermatol Surg Oncol. 1980; 6: 357-368.
13. Epstein EH, Levin DL, Craft JD, Lutzner MA. Mycosis fungoides: survival, prognostic features, response to therapy and autopsy findings. Medicine. 1972; 51: 61-72.
14. Fucks ZY, Bagshow MA, Farber EM. Prognostic signs and the management of mycosis fungoides. Cancer. 1973; 32: 1385-1395.
15. Lamberg SI, Green SB, Byar DP, et al. Status report of 376 mycosis fungoides patients at 4 years: Mycosis Fungoides Cooperative Group. Cancer Treat Rep. 1979; 63: 701-707.
16. Vonderheid EC, Van Scott EJ, Wallner PE, Johnson WC. A 10 year experience with topical mechlorethamine for mycosis fungoides: comparison with patients treated with total-skin electron-beam radiation therapy. Cancer Treat Rep. 1979; 63: 681-689.
17. Bunn PA, Huberman MS, Whang-Peng J, et al. Prospective staging evaluation of patients with cutaneous T-cell lymphomas: demonstration of a high frequency of extracutaneous dissemination. Ann Intern Med. 1980; 93: 223-230.
18. Cohen SR, Stenn KS, Braverman IM, Beck GJ. Mycosis fungoides: clinicopathologic relationships, survival and therapy in 59 patients with observation on occupation as a new prognostic factor. Cancer. 1980; 46: 2654-2666.
19. Van der Loo EM, Meijer CJLM, Scheffer E, Van Vloten WA. The prognostic value of membrane markers and morphometric characteristics of lymphoid cells in blood and lymph nodes from patients with mycosis fungoides. Cancer. 1981; 47: 2671-2677.
20. Green SB, Byar DP, Lamberg SI. Prognostic variables in mycosis fungoides. Cancer. 1981; 47: 2671-2677.
21. Hamminga L, Noordjik K, Van Vloten WA. Total skin electron-beam irradiation vs topical mechlorethamine therapy. Arch Dermatol. 1982; 118: 150-153.
22. Hamminga L, Hermans J, Noordjik K, Meijer CJLM, Scheffer E, Van Vloten WA. Cutaneous T-cell lymphoma: clinicopathologic relationships, therapy and survival in ninety-two patients. Br J Dermatol. 1982; 107: 145-156.
23. Lamberg SI, Green SB, Byar DP, et al. Clinical staging for cutaneous T-cell lymphoma. Ann Intern Med. 1984; 100: 187-192.
24. Sausville EA, Worsham GF, Matthews MJ, et al. Histologic assessment of lymph nodes in mycosis fungoides/Sézary syndrome (cutaneous T-cell lymphoma). Hum Pathol. 1985; 16: 1098-1109.
25. Sausville EA, Eddy JL, Makuch RW, et al. Histopathologic staging at initial diagnosis of mycosis fungoides and Sézary syndrome. Ann Intern Med. 1988; 109: 372-382.
26. Yamamura T, Aozasa K, Sano S. The cutaneous lymphomas with convoluted nucleus. J Am Acad Dermatol. 1984; 10: 796-803.
27. Vonderheid EC, Tan DW, Johnson WC, Van Scott EJ, Wallner PE. Prognostic significance of cytomorphology in the cutaneous T-cell lymphomas. Cancer. 1981; 47: 119-125.
28. Geerst ML. Has morphology of mycosis fungoides a prognostical significance? Presented as a poster exhibit at the International Symposium of Cutaneous Lymphoma; October 28-30, 1988; Copenhagen, Denmark.
29. Vonderheid EC, Tan E, Sabel EL, Schwab E, Micaily B, Jegasothy BV. Clinical implications of immunologic phenotyping in cutaneous T cell lymphoma. J Am Acad Dermatol. 1987; 17: 40-52.
30. Meissner K, Loening T, Rehpenning W. Prognostic significance of CD1 + epidermal cells in patients with cutaneous T-cell lymphomas. Presented as a poster exhibit at the International Symposium of Cutaneous Lymphoma; October 28-30, 1988; Copenhagen, Denmark.
31. Bunn PA, Lamberg SI. Report on the committee of staging and classification of cutaneous T-cell lymphoma. Cancer Treat Rep. 1979; 63: 725-728.
32. Armitage P. Statistical Methods in Medical Research. Boston, Mass: Blackwell Scientific Publications Inc; 1971.
33. Kaplan GL, Meier P. Nonparametric estimations from incomplete observations. J Am Stat Assoc. 1958; 53: 457-481.
34. Peto R, Pike MC. Conservatism of the approximation σ (O — E)2/E in the log-rank test for survival data or tumor incidence data. Biometrics. 1973; 29: 579-584.
35. Cox DR. Regression models and life tables. J R Stat B. 1971; 35: 187-220.
36. Dixon WJ. BMPD Statistical Software. Berkeley, Calif: University of California; 1983.
37. Van Vloten WA, Vermeij J, Vroome H. Total skin electron beam irradiation in mycosis fungoides. Dermatologica. 1977; 155: 28-35.
38. Pereira A, Cervantes E, Montserrat E, Llevaria C, Rozman C. Non-Hodgkin's lymphoma of unfavourable histology: a multivariate analysis predicting the response to CHOP. Hematol Oncol. 1987; 5: 203-211.